143 related articles for article (PubMed ID: 10365725)
21. The efficacy and safety of FSK0808, filgrastim biosimilar: a multicenter, non-randomized study in Japanese patients with breast cancer.
Sagara Y; Sato K; Fukuma E; Higaki K; Mizutani M; Osaki A; Takano T; Tokuda Y; Ohno S; Masuda N; Suzuki M; Saeki T
Jpn J Clin Oncol; 2013 Sep; 43(9):865-73. PubMed ID: 23858037
[TBL] [Abstract][Full Text] [Related]
22. Granulocyte colony-stimulating factors in the management of chemotherapy-induced neutropenia: evidence based review.
Bhana N
Curr Opin Oncol; 2007 Jul; 19(4):328-35. PubMed ID: 17545795
[TBL] [Abstract][Full Text] [Related]
23. Filgrastim for lupus neutropenia.
Euler HH; Schwab UM; Schroeder JO
Lancet; 1994 Nov; 344(8935):1513-4. PubMed ID: 7526104
[No Abstract] [Full Text] [Related]
24. Filgrastim therapy in a child with neutropenia induced by linezolid.
Hernández Segurado M; Arias Moya MÁ; Gómez Pérez M; Bonilla Porras M; Castillo Bazán E; Bécares Martínez FJ; Toledano Mayoral G; Panadero Esteban MI
Int J Clin Pharm; 2013 Aug; 35(4):538-41. PubMed ID: 23820894
[TBL] [Abstract][Full Text] [Related]
25. Probable hypersensitivity reaction to filgrastim.
Martín Muñoz R; Gómez-Bellver MJ; Navarro Pulido AM; Orta Cuevas JC
Am J Health Syst Pharm; 1996 Jul; 53(13):1607. PubMed ID: 8809286
[No Abstract] [Full Text] [Related]
26. Granulocyte concentrate administered via apheresis for a pediatric patient with Kostmann's syndrome.
Narvios AB
Ther Apher Dial; 2010 Feb; 14(1):125. PubMed ID: 20438531
[No Abstract] [Full Text] [Related]
27. Neonatal neutropenia: what diagnostic evaluation is needed and when is treatment recommended?
Del Vecchio A; Christensen RD
Early Hum Dev; 2012 May; 88 Suppl 2():S19-24. PubMed ID: 22633505
[TBL] [Abstract][Full Text] [Related]
28. Using granulocyte colony-stimulating factor for neutropenia during neonatal sepsis.
Murray JC; McClain KL; Wearden ME
Arch Pediatr Adolesc Med; 1994 Jul; 148(7):764-6. PubMed ID: 7517276
[No Abstract] [Full Text] [Related]
29. Neutropenia related to valacyclovir and valganciclovir in 2 renal transplant patients and treatment with granulocyte colony stimulating factor: a case report.
Keles M; Yildirim R; Uyanik A; Turkmen M; Bilen Y; Aydinli B; Cetinkaya R; Polat KY
Exp Clin Transplant; 2010 Jun; 8(2):181-3. PubMed ID: 20565377
[TBL] [Abstract][Full Text] [Related]
30. "Idiopathic neutropenia" in very low birthweight infants.
Juul SE; Calhoun DA; Christensen RD
Acta Paediatr; 1998 Sep; 87(9):963-8. PubMed ID: 9764892
[TBL] [Abstract][Full Text] [Related]
31. Filgrastim and antibiotics treatment reduces neutropenia severity in solid cancer patients.
Hassan BA; Yusoff ZB; Othman SB
Asian Pac J Cancer Prev; 2009; 10(4):641-4. PubMed ID: 19827886
[TBL] [Abstract][Full Text] [Related]
32. Severe congenital neutropenia: a case study.
Parker LA
Neonatal Netw; 1997 Dec; 16(8):17-21. PubMed ID: 9429449
[TBL] [Abstract][Full Text] [Related]
33. Response to granulocyte colony-stimulating factor in an autoimmune neutropenic adult.
Imoto S; Hashimoto M; Miyamoto M; Murayama T; Murayama M; Nakamura M; Matsui T; Chihara K; Ryo R
Acta Haematol; 1999; 101(3):153-6. PubMed ID: 10352336
[TBL] [Abstract][Full Text] [Related]
34. Ten years of colony-stimulating factors: what have we learned? Introduction.
Sylvester RK
Am J Health Syst Pharm; 2002 Apr; 59(7 Suppl 2):S3-5; quiz S28-9. PubMed ID: 11944612
[No Abstract] [Full Text] [Related]
35. Filgrastim. A reappraisal of pharmacoeconomic considerations in the prophylaxis and treatment of chemotherapy-induced neutropenia.
Frampton JE; Faulds D
Pharmacoeconomics; 1996 Jan; 9(1):76-96. PubMed ID: 10161371
[TBL] [Abstract][Full Text] [Related]
36. A randomized case-controlled study of recombinant human granulocyte colony stimulating factor for the treatment of sepsis in preterm neutropenic infants.
Aktaş D; Demirel B; Gürsoy T; Ovalı F
Pediatr Neonatol; 2015 Jun; 56(3):171-5. PubMed ID: 25458637
[TBL] [Abstract][Full Text] [Related]
37. Transient effect of granulocyte colony-stimulating factor in allo-immune neonatal neutropenia.
Girlando P; Zuppa AA; Romagnoli C; Tortorolo G
Biol Neonate; 2000 Nov; 78(4):277-80. PubMed ID: 11093006
[TBL] [Abstract][Full Text] [Related]
38. [Treatment of severe neutropenias in dogs and cats with filgrastim].
Kraft W; Kuffer M
Tierarztl Prax; 1995 Dec; 23(6):609-13. PubMed ID: 8585081
[TBL] [Abstract][Full Text] [Related]
39. [Clinical Investigation of the Effects of Filgrastim BS1 on Neutropenia Following Oral Cancer Chemotherapy (TPF Therapy)].
Uchiyama K; Yamada M; Tamate S; Iwasaki K; Mitomo K; Nakayama S
Gan To Kagaku Ryoho; 2015 Sep; 42(9):1073-6. PubMed ID: 26469162
[TBL] [Abstract][Full Text] [Related]
40. Clinical safety of tbo-filgrastim, a short-acting human granulocyte colony-stimulating factor.
Pettengell R; Bias P; Mueller U; Lang N
Support Care Cancer; 2016 Jun; 24(6):2677-84. PubMed ID: 26780505
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
